Cat 2 CME Report Print Save
  • Facebook
  • LinkedIn
  • Twitter
  • Google Plus
  • Email

Advertisement

Immunogenicity of the 13-valent pneumococcal conjugate vaccine in older adults with and without comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)

Clinical Infectious Diseases

August 21, 2017

van Deursen AMM, et al.

Authors performed an investigation of the long–term immunogenicity of 13–valent pneumococcal conjugate vaccine (PCV13) in pneumococcal vaccine–naive older adults as part of Community–Acquired Pneumonia Immunization Trial in Adults (CAPiTA). In immunocompetent adults ≥65 years of age, PCV13 elicited significant increases in OPA titers and IgG concentrations that persisted 2 years postvaccination for all 13 serotypes, regardless of age and comorbidity.
Read the full article on Clinical Infectious Diseases.

Advertisement

Advertisement

Advertisement

Advertisement

Featured Articles

In the News

Microstructural bone changes biomarker for autoimmunity and RA

In the News

Residents can be sued, too: Experts offer mitigation strategies

In the News

SLE and antiphospholipid antibody syndrome as risk factors for acute coronary...

In the News

The importance of women supporting women in medicine

In the News

Targeting long-haul COVID: An exclusive interview on the latest research

In the News

Successfully navigating state licensure as a resident

In the News

The leap from residency to fellowship: How to apply and interview

In the News

Biologic therapy in pediatrics: Focus on dermatology and rheumatology

In the News

'Step away'—When patients make you furious

In the News

Residents should set these 3 financial priorities

In the News

How to combat sexual harassment in medicine

In the News

Pregnancy during residency? It’s possible, but keep these factors in mind

  • 1
  • 2
  • 3
  • 4
  • 5
  • Last

We Recommend For You

  1. Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects...

    Clinical Trial

  2. Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With...

    Clinical Trial

  3. Childhood deaths attributable to invasive pneumococcal disease in England and...

    Journal Article

  4. Advertisement

  5. Effectiveness of and obstacles to antibiotic streamlining to amoxicillin...

    Journal Article

  6. High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe...

    Journal Article

  7. On this day in medical history: The 100th anniversary of the Spanish Flu

    In the News

  8. Can vitamin E boost immunity against pneumonia in the elderly? A discussion with...

    In the News

  9. Only 1 in 5 older Americans receive recommended pneumococcal vaccines

    In the News

  10. Pneumococcal vaccination rates improved with nurse-led program

    In the News

  11. 11th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD-

    Conference

Sign In

Don't Have Account? Sign Up here.

Password Help

Enter your email address and a password reset email will be sent to you.

or

Log In with Facebook Log In with Google Log In with LinkedIn

Verification

Please submit one of the following:

  • Copy of license
  • Copy of medical school diploma
  • Office website
    (website address should include physician name, medical school, grad year)
Submit to Support@MDLinx.com

— Action Required —

Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.

Turn Off Ad Blocker

We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.